MedTrace Logo

Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology

NCT01359046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2019-05-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare urinary tract infection rates among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter compared to the standard suprapubic catheter.

Conditions

Interventions

DEVICE

silver SPC

subject randomized to receive silver alloy impregnated catheter

DEVICE

standard SPC

subject randomized to receive standard catheter

Sponsors & Collaborators

Principal Investigators

  • John Gebhart, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2018-03-02
Completion
2018-03-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01359046 on ClinicalTrials.gov